MalarVx files Form D for $2.5 million convertible note offering
The Seattle biotech has sold $125,000 of a planned $2.5 million offering as of August 8, 2026, with two investors so far.
SEC filing
Latest
1 story
Sign inSign in1 story
The Seattle biotech has sold $125,000 of a planned $2.5 million offering as of August 8, 2026, with two investors so far.
SEC filing